Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each share held, for a total value of $188.24 per Allergan share.Biotech and Pharmaceuticalsread more
"What else do you have to do that will actually have to affect the Iranians' calculus?" said Amos Hochstein, who served as U.S. special envoy for international energy affairs...World Politicsread more
Reports of tensions may have been sparked by Kraft Heinz's underperformance and because of accounting problems at the packaged goods company.Investingread more
SpaceX used its high speed boat called "Ms. Tree" to catch the nosecone its Falcon 9 rocket after Monday's launch.Investing in Spaceread more
FedEx sued the U.S. government, saying it should not be held liable if it inadvertently shipped products that violated a Trump administration ban on exports to some Chinese...Traderead more
The major indexes have stretched to all-time highs and are riding one of their best first halves in decades.Trading Nationread more
The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
Citi Private Bank says it has maintained an "overweight" stance on stocks in China, Hong Kong, Taiwan and South Korea.Asia Marketsread more
Stocks in Asia slipped on Tuesday, while investors looked toward a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to happen later in the...Asia Marketsread more
A week of dovish fireworks out of the central banking community has just gone by with most of the world's leading central banks now guiding towards easing in light of downside...Commentaryread more
Stifel is getting more bullish on AMD shares because of the chipmaker's rising profit margins and market share gains.
The firm raised its price target for Advanced Micro Devices shares by 81 percent, to $38 from $21, citing strong demand for its new products. The updated forecast is 22 percent higher than Wednesday's closing price. Stifel also reiterated its buy rating for the shares.
New products are helping expand gross profit margins (GM), analyst Kevin Cassidy said in a note to clients Wednesday, also crediting management's solid execution and a delayed competitive response from Intel. "We expect AMD's corporate GM to continue to increase for at least the next four quarters."
Cassidy predicts AMD's new products will raise the chipmaker's gross profit margin to 45 percent in the coming years versus his 40.1 percent estimate for the company's fiscal 2019.
AMD shares closed down less than 1 percent on Thursday.
The analyst cited media reports that Intel is facing a processor shortage due to its delayed transition to the 10 nanometer manufacturing process.
One nanometer equals one-billionth of a meter. Smaller nanometer chipmaking technologies historically have allowed companies to create faster, more power-efficient chips.
"Intel not only hasn't had a competitive response but is likely struggling to meet demand. This opens the door for continued market share gains by AMD, in our view," he said.
AMD's stock is significantly outperforming the market this year. Its shares are up 204 percent year to date through Wednesday versus the S&P 500's 9 percent gain. The company's stock is the top-performing name in the S&P 500 this year.